What does Dr. JAN NOORDSIJ do?

Dr. JAN NOORDSIJ is a healthcare practice in Büllingen. Private Limited, started on 2 June 2010, 1 establishment.

What is the address of Dr. JAN NOORDSIJ?

The registered office of Dr. JAN NOORDSIJ is located at Lanzerath 38, 4760 Büllingen.

Is Dr. JAN NOORDSIJ still active?

Yes. According to the CBE (30 October 2026) Dr. JAN NOORDSIJ is active, legal situation “Normale toestand”, started on 2 June 2010.

Is Dr. JAN NOORDSIJ registered on Peppol?

Yes, Dr. JAN NOORDSIJ is registered on the Peppol network with ID 0208:0826503544.

What is the enterprise number of Dr. JAN NOORDSIJ?

The enterprise number of Dr. JAN NOORDSIJ is BE0826503544.

When was Dr. JAN NOORDSIJ founded?

Dr. JAN NOORDSIJ was founded on 2 June 2010.

Who are the directors of Dr. JAN NOORDSIJ?

According to the 2024 annual accounts, the directors of Dr. JAN NOORDSIJ are: JAN NOORDSIJ.

Is Dr. JAN NOORDSIJ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 June 2010; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Dr. JAN NOORDSIJ make in 2024?

Dr. JAN NOORDSIJ recorded a loss after taxes of € 1,808 in financial year 2024.

What is the revenue of Dr. JAN NOORDSIJ?

As a small company, Dr. JAN NOORDSIJ is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 8,434.

Dr. JAN NOORDSIJ (Private Limited) - Büllingen

Dossier Dr. JAN NOORDSIJ, printed on 30 October 2026 from databakkes.be/en/0826503544/dr-jan-noordsij. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2024.

Financials

Financial year 2024

Dr. JAN NOORDSIJ from Büllingen, company number BE0826503544, closed financial year 2024 with a result of € -1,808 after tax. For that financial year Dr. JAN NOORDSIJ recorded a gross margin of € 8,434 and equity of € 131,950. Compared with financial year 2023, the result moved from € -12,197 to € -1,808. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Healthy

€ 131,950

▼ 1% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1,808

▲ 85 % less loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 250

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 125,750.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 30,451

▼ 4% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 14,908

▲ 43% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4,087

▼ 23% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,950

▼ 13% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 37,209 Gross margin 2021: € 37,209 First fiscal year in the series	€ 46,259 Gross margin 2022: € 46,259 ▲ 24% vs 2021 (€ 37,209) Favourable step	€ -5,629 Gross margin 2023: € -5,629 ▼ € 51,888 vs 2022 (€ 46,259) Unfavourable step	€ 8,434 Gross margin 2024: € 8,434 ▲ € 14,063 vs 2023 (€ -5,629) Favourable step	▲ € 14,063
Profit after taxes	€ 26,248 Profit after taxes 2021: € 26,248 First fiscal year in the series	€ 27,414 Profit after taxes 2022: € 27,414 ▲ 4% vs 2021 (€ 26,248) Favourable step	€ -12,197 Profit after taxes 2023: € -12,197 ▼ € 39,611 vs 2022 (€ 27,414) Unfavourable step	€ -1,808 Profit after taxes 2024: € -1,808 ▲ € 10,388 vs 2023 (€ -12,197) Favourable step	▲ € 10,388
Equity	€ 118,541 Equity 2021: € 118,541 First fiscal year in the series	€ 145,955 Equity 2022: € 145,955 ▲ 23% vs 2021 (€ 118,541) Favourable step	€ 133,758 Equity 2023: € 133,758 ▼ 8% vs 2022 (€ 145,955) Unfavourable step	€ 131,950 Equity 2024: € 131,950 ▼ 1% vs 2023 (€ 133,758) Unfavourable step	▼ 1%
Total debts	€ 104,711 Total debts 2021: € 104,711 First fiscal year in the series	€ 97,115 Total debts 2022: € 97,115 ▼ 7% vs 2021 (€ 104,711) Favourable step	€ 21,437 Total debts 2023: € 21,437 ▼ 78% vs 2022 (€ 97,115) Favourable step	€ 68,660 Total debts 2024: € 68,660 ▲ 220% vs 2023 (€ 21,437) Unfavourable step	▲ 220%
Cash	€ 0 Cash 2021: € 0 First fiscal year in the series	€ 15,226 Cash 2022: € 15,226 Unchanged (€ 0) Favourable step	€ 0 Cash 2023: € 0 ▼ 100% vs 2022 (€ 15,226) Unfavourable step	€ 250 Cash 2024: € 250 Unchanged (€ 0) Favourable step
Retained profit	€ 112,341 Retained profit 2021: € 112,341 First fiscal year in the series	€ 139,755 Retained profit 2022: € 139,755 ▲ 24% vs 2021 (€ 112,341) Favourable step	€ 127,558 Retained profit 2023: € 127,558 ▼ 9% vs 2022 (€ 139,755) Unfavourable step	€ 125,750 Retained profit 2024: € 125,750 ▼ 1% vs 2023 (€ 127,558) Unfavourable step	▼ 1%
Dividend	€ 10,000 Dividend 2021: € 10,000 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 10,000) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 548 Bank debt 2021: € 548 First fiscal year in the series	€ 3,333 Bank debt 2022: € 3,333 ▲ € 2,785 vs 2021 (€ 548) Unfavourable step	€ 10,390 Bank debt 2023: € 10,390 ▲ 212% vs 2022 (€ 3,333) Unfavourable step	€ 14,908 Bank debt 2024: € 14,908 ▲ 43% vs 2023 (€ 10,390) Unfavourable step	▲ 43%
Balance sheet total	€ 223,252 Balance sheet total 2021: € 223,252 First fiscal year in the series	€ 243,070 Balance sheet total 2022: € 243,070 ▲ 9% vs 2021 (€ 223,252) Unchanged	€ 155,195 Balance sheet total 2023: € 155,195 ▼ 36% vs 2022 (€ 243,070) Unchanged	€ 200,610 Balance sheet total 2024: € 200,610 ▲ 29% vs 2023 (€ 155,195) Unchanged	▲ 29%

Key figures of Dr. JAN NOORDSIJ, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. JAN NOORDSIJ?

What happened at Dr. JAN NOORDSIJ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: loss of € 1,808. filed late Source: NBB ↗
2017 JAN NOORDSIJ became a director. NBB
Jul 1, 2010 New establishment in Büllingen. KBO
Jun 2, 2010 Start of the company according to the CBE. KBO

In short

From € 26,248 profit in 2021 to € 1,808 loss in 2024.

Paid € 17,357 in corporate taxes since 2021.

Best year ever: 2022, with € 27,414 profit.

Paid out € 10,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

JAN NOORDSIJ

Dr. JAN NOORDSIJ

Behind Dr. JAN NOORDSIJ is JAN NOORDSIJ.

Directors

According to the 2024 annual accounts

JAN NOORDSIJ

Director

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Lanzerath 38

4760 Büllingen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0826.503.544

VAT number

BE 0826.503.544

Registered office

Lanzerath 38, 4760 Büllingen

Names & denominations

Dr. JAN NOORDSIJ

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 June 2010

Peppol

Active · Active since 2 Jun 2025

Activities · NACE

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

Activiteiten van holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

Activiteiten van medisch specialisten

Verhuur en exploitatie van terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. JAN NOORDSIJ

Warning lights

Financials

What happened to Dr. JAN NOORDSIJ?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions